Mequitamium iodide

This classification denotes a histamine-1 receptor antagonist and antimuscarinic agent with the molecular formula C21H25N2S.I, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50D69ZKZ7M, chemically known as 1-azoniabicyclo(2.2.2)octane, 1-methyl-3-(10h-phenothiazin-10-ylmethyl)-, iodide but generally known as mequitamium iodide, which bears US NIH Compound Identifier 72028. European Medicines Agency schedules Mequitamium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08765MIG. The term MEQUITAMIUM IODIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). Most nations schedule mequitamium iodide under HS 29343090 and SITC 51578. As of Q4 2014, MEQUITAMIUM IODIDE remains the US FDA Preferred Term for this commodity. Mequitamium iodide bears US NLM identifiers UMLS ID C0064889 and NCI Concept Code C83919. SMILES: C[N+]12CCC(CC1)C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53.[I-].